MeiraGTx to Present at Barclays Gene Editing & Gene Therapy SummitPR Newswire (press release)NEW YORK and LONDON, Nov. 28, 2017 /PRNewswire/ — MeiraGTx, a New York and London based gene therapy company, today announced that Alexandria Forbes, Ph… Continue reading
FierceBiotech |
UCL, Synpromics ally to develop Parkinson’s gene therapy
FierceBiotech Multiple research groups are working on programs that fall under the umbrella of Parkinson’s gene therapies. Early efforts entered the clinic years ago. A more recent entrant, Voyager Therapeutics, posted early clinical data on its attempt to improve … Synpromics Announces Collaboration with UCL to Develop …Business Wire (press release) New Gene Therapy for Parkinson’s will be Developed in the UKLabiotech.eu (blog) |
Genetic Literacy Project |
How gene therapy can help fight methamphetamine addiction
Genetic Literacy Project Gene therapy, which modifies a person’s DNA, has long been thought of as a way to treat genetic diseases—and, more recently, cancer. But a team at the University of Arkansas for Medical Sciences thinks it can use this same idea to treat addiction by … |
Science News (blog) |
Parents may one day be morally obligated to edit their baby’s genes
Science News (blog) But thanks to recent advances in gene-editing tools such as CRISPR/Cas9, genetic manipulation of human embryos is becoming reality. Soon, designer babies like those described in the film may even become morally mandatory, some ethicists say. Gattaca’s … |
|
Synpromics Announces Collaboration with UCL to Develop Revolutionary Gene Therapy for Parkinson’s Disease
Business Wire (press release) EDINBURGH, Scotland–(BUSINESS WIRE)–Synpromics Ltd is pleased to announce a new collaboration with UCL to generate a range of synthetic gene promoters for the central nervous system (CNS), to develop a gene therapy for Parkinson’s disease. |